← SynDRA
TINODASERTIB
SynDRA canonical compound SYN0039331 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | MKNK1 | MKNK2 |
|---|
| Mechanism of action | MAPK-interacting kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- MKNK1 INHIBITOR
- MKNK2 INHIBITOR
- MAPK-interacting kinase inhibitor
Cross-references
Synonyms
- Aum001
- Etc-206
- AUM-001
- ETC1907206
- ETC-206
- AUM001
- ETC206
- MND3WX2R7I
- ETC-1907206
- RefChem:1100138
- ETC-206 (AUM 001)
- tinodasertib [INN]
- MFCD31692387
- UNII-MND3WX2R7I
- orb1308323
- SCHEMBL15288605
- GTPL12385
- FWRFPHJSGLYXTD-UHFFFAOYSA-N
- US9908886, Example 96
- BDBM375544
- GLXC-15156
- ETC-206?
- EX-A4504
- PIC15133
- s6658
- AKOS040741712
- compound 48 [PMID: 29683667]
- DA-53018
- MS-27017
- HY-112424
- CS-0046041
- F88611
- T15250
Look up TINODASERTIB in the interactive SynDRA portal →